European Urology Open Science (Jul 2020)

Results of a phase II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin (BCG) VPM1002BC in patients with BCG failure - SAKK 06/14

  • C.A. Rentsch,
  • G. Thalmann,
  • I. Lucca,
  • M. Kwiatkowski,
  • G. Wirth,
  • R. Strebel,
  • D. Engeler,
  • A. Pedrazzini,
  • C. Hüttenbrink,
  • W. Schultze-Seemann,
  • L. Bubendorf,
  • A. Wicki,
  • B. Roth,
  • P. Bosshard,
  • H. Püschel,
  • D. Boll,
  • L. Hefermehl,
  • F. Roghmann,
  • M. Gierth,
  • S. Schäfer,
  • S. Hayoz

Journal volume & issue
Vol. 19
pp. e1183 – e1184

Abstract

Read online

No abstracts available.